The crucial role of IL-8 in lung inflammation and disease pathogenesis might suggest IL-8 as a possible new therapeutic target to efficiently modulate the hyperinflammatory response in ARDS. This evidence concerns the gene CXCL8 and acute respiratory distress syndrome.